References

1. Mahgoub ES, Murray IG. Mycetoma. London: William Heinemann Medical, 1973.

2. Mariat F. Sur la distribution geographique et la repartition des agents des mycetomes. Bull Soc Path Exot 1963;56:35-45.

3. Hay RJ, Mackenzie DWR. Mycetoma (Madura foot) in the United Kingdom - a survey of 44 cases. Clin Exp Dermatol 1983;8:553-62.

4. Hay RJ, Mahgoub ES, Leon G et al. Mycetoma. J Med Vet Mycol 1992;30(Suppl. 1):41-9.

5. Boiron P, Locci R, Goodfellow M et al Nocardia, nocardiosis and mycetoma. Med Mycol 1998;36(Suppl. 1):26-37.

6. Welsh O, Salinas MC, Rodriguez MA. Treatment of eumycetoma and actinomycetoma. Curr Top Med Mycol 1995;6:47-71.

7. Ramam M, Garg T, D'Souza P et al. A two-step schedule for the treatment of actinomycotic mycetomas. Acta Derm Venereol 2000;80:378-80.

8. Gugnani HC, Ezeanolue BC, Khalil M et al. Fluconazole in the therapy of tropical deep mycoses. Mycoses 1995;38:485-8.

9. Paugam A, Tourte-Schaefer C, Keita A et al. Clinical cure of fungal madura foot with oral itraconazole. Cutis 1997;60:191-3.

10. Lee MW, Kim JC, Choi JS, Kim KH, Greer DL. Mycetoma caused by Acremonium falciforme: successful treatment with itraconazole. J Am Acad Dermatol 1995;32:897-900.

11. Hay RJ. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses. Br J Dermatol 1999;141(Suppl. 56):36-40.

12. Subrahmanyam M. Intra-arterial chemotherapy for mycetoma of the foot. Br J Surg 1995;82:643.

13. Ghosh A, Chakrabarti A, Sharma VK, Singh K, Singh A. Sporotrichosis in Himachal Pradesh (north India). Trans R Soc Trop Med Hyg 1999;93:41-5.

14. Conias S, Wilson P. Epidemic cutaneous sporotrichosis:report of 16 cases in Queensland due to mouldy hay. Aust J Dermatol 1998;39:34-7.

15. Pappas PG, Tellez I, Deep AE et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect. Dis 2000;30:65-70.

16. Tobin EH, Jih WW. Sporotrichoid lymphocutaneous infections: etiology, diagnosis and therapy. Am Fam Phys 2001;63:326-32.

17. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis 1995;21:981-5.

18. Noguchi H, Hiruma M, Kawada A. Case report. Sporotrichosis successfully treated with itraconazole in Japan. Mycoses 1999;42:571-6.

19. Karakayali G, Lenk N, Alli N, Gungor E, Artuz F. Itraconazole therapy in lymphocutaneous sporotrichosis: a case report and review of the literature. Cutis 1998;61:106-7.

20. Kauffman CA, Pappas PG, McKinsey DS et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis 1996;22:46-50.

21. Cabezas C, Bustamante B, Holgado W, Begue RE. Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide. Pediatr Infect Dis J 1996;15:352-4.

22. Kauffman CA, Hajjeh R, Chapman SW. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America. Clin Infect Dis 2000;30:684-7.

23. Bargman H. Successful treatment of cutaneous sporotrichosis with liquid nitrogen:report of three cases. Int J Dermatol 1995;38:285-7.

24. Minotto R, Bernardi CD, Mallmann LF et al. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol 2001;44:585-92.

25. Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses 2001;44:1-7.

26. Esterre P, Inzan CK, Ramarcel ER et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol 1996:134(Suppl. 46):33-6.

27. Tanuma H, Hiramatsu M, Mukai H et al. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan. Mycoses 2000:43:79-83.

28. Guerriero C, De Simone C, Tulli A. A case of chromoblastomycosis due to Phialophora verrucosa responding to treatment with fluconazole. Eur J Dermatol 1998;8:167-8.

29. Kombila M, Gomez de Diaz M, Richard-Lenoble D et al. Chromoblastomycosis in Gabon. Study of 64 cases. Sante 1995;5:235-44.

30. Kullavanijaya P, Rojanavanich V. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy. Int J Dermatol 1995;34:804-7.

31. Hiruma M, Kawada A, Yoshida M, Kouya M. Hyperthermic treatment of chromomycosis with disposable chemical pocket warmers. Report of a successfully treated case, with a review of the literature. Mycopathologia 1993;122:107-14.

32. Kumarasinghe SP, Kumarasinghe MP. Itraconazole pulse therapy in chromoblastomycosis. Eur J Dermatol 2000;10:220-2.

33. Poirriez J, Breuillard F, Francois N et al. A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am J Trop Med Hyg 2000:63:61-3.

34. Bonifaz A, Martinez-Soto E, Carrasco-Gerrard E, Peniche J. Treatment of chromoblastomycosis with itraconazole, cryosurgery and a combination of both. Int J Dermatol 1997:36:542-7.

35. Patel P, Ramanathan J, Kayser M, Baran J Jr. Primary cutaneous cryptococcosis of the nose in an immunocompetent woman. J Am Acad Dermatol 2000:43:344-5.

36. Noble RC, Fajardo LF. Primary cutaneous cryptococcosis: review and morphologic study. Am J Clin Pathol 1972:57:13-22.

37. Antony SA, Antony SJ. Primary cutaneous cryptococcus in nonimmunocompromised patients. Cutis 1995:56:96-8.

38. Hamann ID, Gillespie RJ, Ferguson JK. Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent host. Aust J Dermatol 1997;38:29-32.

39. Sanchez P, Bosch RJ, de Galvez MV et al. Cutaneous cryptococcosis in two patients with acquired immunodeficiency syndrome. Int J STD AIDS 2000;11:477-80.

40. Coker LR, Swain R, Morris R, McCall CO. Disseminated cryptococcosis presenting as pseudofolliculitis in an AIDS patient. Cutis 2000;66:207-10.

41. Naka W, Masuda M, Konohana A et al. Primary cutaneous cryptococcosis and Cryptococcus neoformans serotype D. Clin Exp Dermatol 1995;20:221-5.

42. Glassman SJ, Hale MJ. Cutaneous cryptococcosis and Kaposi's sarcoma occurring in the same lesions in a patient with the acquired immunodeficiency syndrome. Clin Exp Dermatol 1995;20:480-6.

0 0

Post a comment